Osteoporotic fx in AS Abstract #0388 #ACR22 @RheumNow 🦴2k adults in RISE, mean age 68y, 44% female, 76% white 🦴Higher risk with: older age, increased comorbidity index, OP history, chronic use of opioids, low BMI 🦴Men and women were equally likely to fracture

Multiplex peripheral blood in 200+ ILD pts Differences in IL-17 RD-ILD>IPF> IPAF Higher IL-13 strongly asso w/ non-progression of ILD in RD-ILD, IPF & IPAF OR 0.4 Almost surprising considering known profibrotic role of IL-13 🧐 https://t.co/21UMq6w9hI Abs#1109 #ACR22 @Rheumnow https://t.co/7tfk74zH8A

• High Interleukin-13 Level Is Associated with Disease Stability in Interstitial …

#ACR22 Abstr#0826 2 years on since FDA approved #Tocilizumab in Adults Onset Still's Disease, real-world data from Japan affirmed its effectiveness and as a steroid-sparring agent @RheumNow https://t.co/jbmhEnGwXO

Stop repeating the #ANA test! 46% of all ANA tests were repeat tests in this study. #HealthCareCost #NoUtility #ChooseWisely abst#1278 @rheumnow #ACR22 https://t.co/K7oyqJYvi9

• ANA Testing Practices in the United States: A Population-Based Study Between 20…

Limited utility for using bone turnover markers in osteoporosis. Perhaps useful to assess adherence to oral therapy. @RheumNow #ACR22 #osteoporosis https://t.co/g6f7SnOzNR

Puechal et al RTX vs CYC induction in GPA: target trial emulation study. BVAS 0 and pred=<10mg at 6 months 73% RTX vs 40% CYC. RR 1.82[95%CI:1.22;2.73] @RheumNow #ACR22 Abstr#1084 https://t.co/6e8wutMC2H https://t.co/OpeajFVdJf

• Rituximab versus Cyclophosphamide for Induction Therapy in Granulomatosis with …

#ACR22 Advancing Telemedicine in Rheumatology '60% prefer telemedicine for routine visits and review lab results' https://t.co/HUgoocXodE @RheumNow #ACR22

• https://onlinelibrary.wiley.com/doi/epdf/10.1002/acr.24860

Tofa 5 mg BID successful in treating refractory uveitis in reducing inflammation and reducing steroid dosage. Abs 1041 #ACR22 @RheumNow https://t.co/dtAEhW7dEG https://t.co/Xbw2iEsYHh

• Tofacitinib in Refractory Uveitis – an Observational Study - ACR Meeting Abstra…

#abs0948 #acr22 @rheumnow perception on fertility&ART in pts w/rheum Dx: 60% believe their Dx affects fertility/25% believe meds do: most cited MTX, steroids, TNFi, HCQ, NSAIDs. 92% heard of ART but unsure if safe or successful w/their Dx. Hx of infertility 29%/only 52% go w/ART https://t.co/lmaM773gP5

There are good reasons why you might want to treat pre-RA. Hard to walk past this promise #ACR22 @RheumNow https://t.co/YHmIl5dsID

Did you know? Teratogens may take the form of: ✳️Drugs & chemicals ✳️Physical agents ✳️Infections ✳️Metabolic conditions #ACR22 @Rheumnow #MedTwitter https://t.co/GfHL28RYjm

USA vs Canada It's kicking off and a super hot topic The Great Debate: To Treat or Not? The Role of DMARDS in Subclinical Rheumatoid Arthritis Holers/Deane (treat 🇺🇸) El Gabalawy/Pope (don't treat 🇨🇦) What more do you want, #ACR22? Bring it on @RheumNow https://t.co/DroQdnSQHf

Terrier @TerrierBen et al Mepolizumab in vasculitic type EGPA in MIRRA. Vasculitic features similar in patients who did/did not achieve remission. Decreased flares of all type, including vasculitic. @RheumNow #ACR22 Abstr#1075 https://t.co/0MkJvnCnf1 https://t.co/ZxbDqlvgae

• Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polya…

Favorable kidney outcomes observed for BEL vs PBO in pts with SLE, including fewer kidney flares, greater kidney improvement (SELENA-SLEDAI), less kidney worsening (BILAG), and improved eGFR. Abs 0352 #ACR22 @RheumNow https://t.co/w50uEYVDup https://t.co/JyKZEZG6DZ

• The Effect of Belimumab (BEL) on Kidney Outcomes in SLE: Results of a Large Int…

Bekker et al. Safety of avacopan across 3 trials. Rates of AEs, SAEs, infection all lower in avacopan group. @RheumNow #ACR22 Abstr#1077 https://t.co/n4zhC2zf8k https://t.co/Q8raSEERah

• Safety of Avacopan in ANCA-Associated Vasculitis: Combined Data from Three Clin…